Autoimmune Disease Diagnosis Market

Autoimmune Disease Diagnosis Market by Product (Consumables, Assay Kits, Instruments), Test Type (Inflammatory Markers, Routine Laboratory Tests), Disease (RA, SLE, Thyroiditis, Scleroderma), End User (Hospitals, Clinical Labs) – Global Forecast to 2025

Report Code: MD 5936 Apr, 2020, by marketsandmarkets.com
COVID-19

Get in-depth analysis of the COVID-19 impact on the Autoimmune Disease Diagnosis Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Autoimmune Disease Diagnosis Market

Request For Special Pricing

[150 Pages Report] The global autoimmune disease diagnosis market size is expected to grow from USD 6.3 billion by 2025 from USD 4.1 billion in 2020, at a CAGR of 8.9%. This industry is experiencing significant growth due to the high incidence of autoimmune diseases, increasing awareness about autoimmune diseases, and the growth in research on autoimmune diseases.

Autoimmune Disease Diagnosis Market

Consumables & assay kits segment to dominate the autoimmune disease diagnosis market in 2019

Based on the product, the autoimmune disease diagnosis industry is segmented into consumables & assay kits and instruments. The consumables & assay kits segment is expected to grow at the highest growth rate during the forecast period. This is attributed primarily to the rising incidence of autoimmune disease and the increasing number of product launches/approvals.

Routine laboratory tests segment to dominate the autoimmune disease diagnosis market in 2019

Based on the test type, the autoimmune disease diagnosis industry is segmented into routine laboratory tests, inflammatory markers, autoantibodies & immunologic tests, and other tests. The routine laboratory tests segment is estimated to register the highest CAGR during the forecast period. This can primarily be attributed to the increasing prevalence of autoimmune diseases coupled with advanced healthcare infrastructure in the region.

Autoimmune Disease Diagnosis Market

Europe was the largest regional market for autoimmune disease diagnosis in 2019

The autoimmune disease diagnosis market has been analyzed for North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2019, Europe held the largest share of the market, followed by Asia Pacific. The rising incidences of chronic diseases, the increasing geriatric population in this region are the major factors driving the growth of the autoimmune disease diagnosis industry in Europe.

Key Market Players:

The prominent players operating in autoimmune disease diagnosis market include Thermo Fisher Scientific (US), Siemens (Germany), Abbott (US), Danaher (US), Bio-Rad Laboratories (US), Grifols (Spain), Trinity Biotech (Ireland), Werfen (Spain), HYCOR Biomedical (US), EUROIMMUN AG (Germany), Oncimmune (UK), HTG Molecular Diagnostics (US), Seramun Diagnostica GmbH (Germany), Exagen Inc. (US), Cambridge Life Sciences Limited (UK), A. Menarini Diagnostics s.r.l (Italy), ORGENTEC Diagnostika (Germany), KRONUS (US), and AESKU GROUP GMBH & CO. KG (Germany).

Siemens AG (Germany) is one of the leading players in the autoimmune disease diagnosis market in 2019. The company offers a broad product portfolio across the globe. Over the years, the company has maintained its leading position in the market.

Scope of the report

Report Metric

Details

Market size available for years

2018–2025

Base year considered

2018

Forecast period

2020–2025

Forecast units

Value (USD)

Segments covered

Product, Test Type, Disease, End User, And Region

Geographies covered

North America (US and Canada), Europe (Germany, France, UK, Italy, Spain, and the RoE), APAC (China, Japan, India, Australia, and the RoAPAC), Latin America and Middle East & Africa

Companies covered

Twenty major players were covered, including
Thermo Fisher Scientific (US), Siemens (Germany), Abbott (US), Danaher (US), Bio-Rad Laboratories (US), Grifols (Spain), Trinity Biotech (Ireland), Werfen (Spain), HYCOR Biomedical (US), EUROIMMUN AG (Germany), Oncimmune (UK), HTG Molecular Diagnostics (US), Seramun Diagnostica GmbH (Germany), Exagen Inc. (US), Cambridge Life Sciences Limited (UK), A. Menarini Diagnostics s.r.l (Italy), ORGENTEC Diagnostika (Germany), KRONUS (US), and AESKU.GROUP GMBH & CO. KG (Germany).

This research report categorizes the autoimmune disease diagnosis market into the following segments and subsegments:

By Product

  • Consumables & Assay Kits
  • Instruments

By Test Type

  • Routine Laboratory Tests
  • Inflammatory Markers
  • Autoantibodies & Immunologic Test
  • Other Tests

By Disease

  • Rheumatoid Arthritis
  • Systemic Lupus Erythematosus
  • Sjφgren’s Syndrome
  • Thyroiditis
  • Scleroderma
  • Other Diseases

By End User

  • Clinical Laboratories
  • Hospitals
  • Other End Users

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • RoE
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America
  • Middle East & Africa

Recent Developments

  • In 2019, Cambridge Life Sciences Limited launched ZEUS IFA Test Systems in the US.
  • In 2019, PerkinElmer, Inc. received approval from the US FDA EUROIMMUN Anti-Tissue Transglutaminase ELISA to help clinicians confirm or exclude a celiac disease diagnosis.
  • In 2019, Exagen Inc. extended its agreement with GSK for a third year to drive greater awareness about challenges facing lupus diagnosis and management.

Key Questions Addressed by the Report

  • What are the various autoimmune disease diagnosisand their respective market shares in the overall market?
  • Where will these developments shape the industry in the mid-to-long term?
  • What are the recent trends affecting the autoimmune disease diagnosis market?
  • Who are the key players in the market, and how intense is the competition?
  • What are the new trends and advancements in the autoimmune disease diagnosis market?

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 17)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 LIMITATIONS
    1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY (Page No. - 20)
    2.1 RESEARCH DATA
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
    2.2 MARKET SIZE ESTIMATION
           2.2.1 BOTTOM-UP APPROACH
           2.2.2 GROWTH FORECAST
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION

3 EXECUTIVE SUMMARY (Page No. - 26)

4 PREMIUM INSIGHTS (Page No. - 30)
    4.1 ATTRACTIVE MARKET OPPORTUNITIES IN THE AUTOIMMUNE DISEASE DIAGNOSIS MARKET
    4.2 ASIA PACIFIC MARKET: BY DISEASE
    4.3 AUTOIMMUNE DISEASE DIAGNOSIS MARKET: GEOGRAPHIC SNAPSHOT

5 MARKET OVERVIEW (Page No. - 33)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           5.2.1 DRIVERS
                    5.2.1.1 High incidence and prevalence of autoimmune diseases
                    5.2.1.2 Increasing awareness about autoimmune diseases
                    5.2.1.3 Growth in the number of research activities on autoimmune diseases
           5.2.2 RESTRAINTS
                    5.2.2.1 High capital requirements
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Use of biosensors for autoimmune disease diagnosis
           5.2.4 TRENDS
                    5.2.4.1 Growth in the number of reagent rental agreements

6 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT (Page No. - 38)
    6.1 INTRODUCTION
    6.2 CONSUMABLES & ASSAY KITS
           6.2.1 NEED FOR THE RAPID DETECTION OF AUTOIMMUNE DISEASES TO DRIVE THE DEMAND FOR CONSUMABLES AND ASSAY KITS
    6.3 INSTRUMENTS
           6.3.1 INSTRUMENTS SEGMENT TO RECORD SIGNIFICANT GROWTH DURING THE FORECAST PERIOD

7 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE (Page No. - 42)
    7.1 INTRODUCTION
    7.2 ROUTINE LABORATORY TESTS
           7.2.1 RISING NUMBER OF ROUTINE HEALTH CHECK-UPS TO SUPPORT MARKET GROWTH
    7.3 INFLAMMATORY MARKERS
           7.3.1 ABILITY OF INFLAMMATORY MARKERS TO DETECT ABNORMALITIES EFFICIENTLY TO DRIVE THEIR DEMAND
    7.4 AUTOANTIBODIES AND IMMUNOLOGIC TESTS
           7.4.1 ADOPTION OF NOVEL IMMUNOLOGY TESTS TO DRIVE MARKET GROWTH
    7.5 OTHER TESTS

8 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE (Page No. - 47)
    8.1 INTRODUCTION
    8.2 RHEUMATOID ARTHRITIS
           8.2.1 INCREASING INCIDENCE OF RHEUMATOID ARTHRITIS TO SUPPORT MARKET GROWTH
    8.3 SYSTEMIC LUPUS ERYTHEMATOSUS
           8.3.1 RISING PREVALENCE OF LUPUS TO SUPPORT MARKET GROWTH
    8.4 SJΦGREN’S SYNDROME
           8.4.1 RISING AWARENESS REGARDING SJΦGREN’S SYNDROME TO SUPPORT MARKET GROWTH
    8.5 THYROIDITIS
           8.5.1 RISING PREVALENCE OF THYROID DISORDERS TO DRIVE MARKET GROWTH
    8.6 SCLERODERMA
           8.6.1 INCREASING INCIDENCE OF SKIN DISORDERS TO DRIVE MARKET GROWTH
    8.7 OTHER DISEASES

9 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER (Page No. - 54)
    9.1 INTRODUCTION
    9.2 CLINICAL LABORATORIES
           9.2.1 INCREASING INCIDENCE OF AUTOIMMUNE DISEASES TO INCREASE TESTING VOLUME IN CLINICAL LABORATORIES
    9.3 HOSPITALS
           9.3.1 INCREASING GOVERNMENT INITIATIVES TO PROVIDE QUALITY TREATMENT FOR AUTOIMMUNE DISEASES TO SUPPORT MARKET GROWTH
    9.4 OTHER END USERS

10 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY REGION (Page No. - 58)
     10.1 INTRODUCTION
     10.2 NORTH AMERICA
             10.2.1 US
                        10.2.1.1 Rising expenditure on autoimmune disease R&D to drive market growth in the US
             10.2.2 CANADA
                        10.2.2.1 Rising prevalence of autoimmune diseases to support market growth
     10.3 EUROPE
             10.3.1 GERMANY
                        10.3.1.1 Rising healthcare expenditure to drive market growth in Germany
             10.3.2 UK
                        10.3.2.1 Rising prevalence of autoimmune diseases to drive market growth in the UK
             10.3.3 FRANCE
                        10.3.3.1 High prevalence of multiple sclerosis to drive market growth in France
             10.3.4 ITALY
                        10.3.4.1 Increasing life science R&D expenditure to support market growth in Italy
             10.3.5 SPAIN
                        10.3.5.1 Research activities conducted in the country to drive market growth in Spain
             10.3.6 REST OF EUROPE
     10.4 ASIA PACIFIC
             10.4.1 CHINA
                        10.4.1.1 Outbreak of COVID-19 to hamper market growth during the forecast period
             10.4.2 INDIA
                        10.4.2.1 Development of antibody tests to support market growth in India
             10.4.3 JAPAN
                        10.4.3.1 Rising healthcare expenditure to support market growth in Japan
             10.4.4 AUSTRALIA
                        10.4.4.1 Rising prevalence of autoimmune diseases to drive market growth in Australia
             10.4.5 REST OF ASIA PACIFIC
     10.5 MIDDLE EAST & AFRICA
             10.5.1 RISING INCIDENCE OF AUTOIMMUNE DISEASES TO SUPPORT MARKET GROWTH IN THE MIDDLE EAST AND AFRICA
     10.6 LATIN AMERICA
             10.6.1 HIGH PREVALENCE OF RHEUMATOID ARTHRITIS TO SUPPORT MARKET GROWTH IN LATIN AMERICA

11 COMPETITIVE LANDSCAPE (Page No. - 94)
     11.1 OVERVIEW
     11.2 MARKET SHARE ANALYSIS, 2018
     11.3 COMPETITIVE SCENARIO
             11.3.1 PRODUCT LAUNCHES (2017-2020)
             11.3.2 PRODUCT APPROVALS (2017-2020)
             11.3.3 PARTNERSHIPS
             11.3.4 ACQUISITIONS (2017-2020)
             11.3.5 COLLABORATIONS (2017-2020)
     11.4 COMPETITIVE LEADERSHIP MAPPING (2018)
             11.4.1 VISIONARY LEADERS
             11.4.2 INNOVATORS
             11.4.3 DYNAMIC DIFFERENTIATORS
             11.4.4 EMERGING COMPANIES

12 COMPANY PROFILES (Page No. - 101)
(Business Overview, Products Offered, Recent Developments, and MnM View)* 
     12.1 THERMO FISHER SCIENTIFIC
     12.2 SIEMENS
     12.3 ABBOTT
     12.4 DANAHER
     12.5 BIO-RAD LABORATORIES
     12.6 GRIFOLS
     12.7 TRINITY BIOTECH
     12.8 WERFEN
     12.9 HYCOR BIOMEDICAL
     12.10 EUROIMMUN
     12.11 ONCIMMUNE
     12.12 HTG MOLECULAR DIAGNOSTICS, INC.
     12.13 SERAMUN DIAGNOSTICA GMBH
     12.14 EXAGEN INC.
     12.15 CAMBRIDGE LIFE SCIENCES LIMITED
     12.16 A. MENARINI DIAGNOSTICS S.R.L
     12.17 ORGENTEC DIAGNOSTIKA
     12.18 KRONUS
     12.19 ERBA GROUP
     12.20 AESKU.GROUP GMBH & CO. KG
* Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies. 

13 APPENDIX (Page No. - 143)
     13.1 INSIGHTS FROM INDUSTRY EXPERTS
     13.2 DISCUSSION GUIDE
     13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     13.4 AVAILABLE CUSTOMIZATIONS
     13.5 RELATED REPORTS
     13.6 AUTHOR DETAILS


LIST OF TABLES (96 Tables)

TABLE 1 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 2 AUTOIMMUNE DISEASE DIAGNOSIS CONSUMABLES & ASSAY KITS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 3 AUTOIMMUNE DISEASE DIAGNOSIS INSTRUMENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 4 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 5 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR ROUTINE LABORATORY TESTS, BY REGION, 2018–2025 (USD MILLION)
TABLE 6 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR INFLAMMATORY MARKERS, BY REGION, 2018–2025 (USD MILLION)
TABLE 7 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR AUTOANTIBODIES AND IMMUNOLOGIC TESTS, BY REGION, 2018–2025 (USD MILLION)
TABLE 8 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR OTHER TESTS, BY REGION, 2018–2025 (USD MILLION)
TABLE 9 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 10 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR RHEUMATOID ARTHRITIS, BY REGION, 2018–2025 (USD MILLION)
TABLE 11 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR SYSTEMIC LUPUS ERYTHEMATOSUS, BY REGION, 2018–2025 (USD MILLION)
TABLE 12 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR SJΦGREN’S SYNDROME, BY REGION, 2018–2025 (USD MILLION)
TABLE 13 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR THYROIDITIS, BY REGION, 2018–2025 (USD MILLION)
TABLE 14 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR SCLERODERMA, BY REGION, 2018–2025 (USD MILLION)
TABLE 15 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR OTHER DISEASES, BY REGION, 2018–2025 (USD MILLION)
TABLE 16 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER,2018–2025 (USD MILLION)
TABLE 17 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR CLINICAL LABORATORIES, BY REGION, 2018–2025 (USD MILLION)
TABLE 18 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR HOSPITALS, BY REGION, 2018–2025 (USD MILLION)
TABLE 19 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR OTHER END USERS, BY REGION, 2018–2025 (USD MILLION)
TABLE 20 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 21 NORTH AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 22 NORTH AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 23 NORTH AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 24 NORTH AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 25 NORTH AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 26 EXPENDITURE ON AUTOIMMUNE DISEASE R&D BY THE NATIONAL INSTITUTES OF HEALTH, 2016–2019
TABLE 27 US: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 28 US: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE,2018–2025 (USD MILLION)
TABLE 29 US: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 30 US: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 31 CANADA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 32 CANADA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 33 CANADA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 34 CANADA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 35 EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 36 EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT,2018–2025 (USD MILLION)
TABLE 37 EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 38 EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 39 EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER,2018–2025 (USD MILLION)
TABLE 40 GERMANY: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 41 GERMANY: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 42 GERMANY: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 43 GERMANY: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 44 UK: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 45 UK: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 46 UK: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 47 UK: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 48 FRANCE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 49 FRANCE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 50 FRANCE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 51 FRANCE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 52 ITALY: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 53 ITALY: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 54 ITALY: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 55 ITALY: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 56 SPAIN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 57 SPAIN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 58 SPAIN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 59 SPAIN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 60 REST OF EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 61 REST OF EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 62 REST OF EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 63 REST OF EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 64 ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 65 ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 66 ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 67 ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE,2018–2025 (USD MILLION)
TABLE 68 ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 69 CHINA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 70 CHINA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 71 CHINA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 72 CHINA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 73 INDIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 74 INDIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 75 INDIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 76 INDIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 77 JAPAN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 78 JAPAN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 79 JAPAN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 80 JAPAN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 81 AUSTRALIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 82 AUSTRALIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 83 AUSTRALIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 84 AUSTRALIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 85 REST OF ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 86 REST OF ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 87 REST OF ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 88 REST OF ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 89 MIDDLE EAST & AFRICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 90 MIDDLE EAST & AFRICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 91 MIDDLE EAST & AFRICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 92 MIDDLE EAST & AFRICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 93 LATIN AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 94 LATIN AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)
TABLE 95 LATIN AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 96 LATIN AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018–2025 (USD MILLION)


LIST OF FIGURES (34 Figures)

FIGURE 1 AUTOIMMUNE DISEASE DIAGNOSIS MARKET SEGMENTATION
FIGURE 2 RESEARCH DESIGN
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
FIGURE 5 MARKET SIZE ESTIMATION FROM THE PARENT MARKET
FIGURE 6 DATA TRIANGULATION METHODOLOGY
FIGURE 7 ASSUMPTIONS FOR THE STUDY
FIGURE 8 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
FIGURE 9 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 10 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2020 VS. 2025 (USD MILLION)
FIGURE 11 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
FIGURE 12 GEOGRAPHIC SNAPSHOT OF THE GLOBAL AUTOIMMUNE DISEASE DIAGNOSIS MARKET
FIGURE 13 HIGH INCIDENCE & LARGE ECONOMIC BURDEN OF AUTOIMMUNE DISEASES TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD
FIGURE 14 RHEUMATOID ARTHRITIS SEGMENT DOMINATED THE APAC MARKET IN 2019
FIGURE 15 JAPAN TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
FIGURE 16 AUTOIMMUNE DISEASE DIAGNOSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & TRENDS
FIGURE 17 NORTH AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET SNAPSHOT
FIGURE 18 EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET SNAPSHOT
FIGURE 19 ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET SNAPSHOT
FIGURE 20 PRODUCT LAUNCHES–THE MOST ADOPTED GROWTH STRATEGY FROM 2017 TO 2020
FIGURE 21 SHARES OF TOP COMPANIES IN THE GLOBAL AUTOIMMUNE DISEASE DIAGNOSIS MARKET (2018)
FIGURE 22 AUTOIMMUNE DISEASE DIAGNOSIS MARKET: GLOBAL COMPETITIVE LEADERSHIP MAPPING, 2018
FIGURE 23 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
FIGURE 24 SIEMENS: COMPANY SNAPSHOT
FIGURE 25 ABBOTT: COMPANY SNAPSHOT
FIGURE 26 DANAHER: COMPANY SNAPSHOT
FIGURE 27 BIO-RAD LABORATORIES: COMPANY SNAPSHOT
FIGURE 28 GRIFOLS: COMPANY SNAPSHOT
FIGURE 29 TRINITY BIOTECH: COMPANY SNAPSHOT
FIGURE 30 WERFEN: COMPANY SNAPSHOT
FIGURE 31 PERKINELMER, INC.: COMPANY SNAPSHOT
FIGURE 32 ONCIMMUNE: COMPANY SNAPSHOT
FIGURE 33 HTG MOLECULAR DIAGNOSTICS, INC.: COMPANY SNAPSHOT
FIGURE 34 EXAGEN INC.: COMPANY SNAPSHOT

The study involved four major activities in estimating the current size of the autoimmune disease diagnosis market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Then, both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

Secondary Research

The secondary sources referred to for research study on the autoimmune disease diagnosis market include publications from government sources such as white papers; articles from recognized authors; gold standard and silver standard websites, directories, and databases; corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; research journals; press releases; and trade, business, and professional associations were referred to identify and collect information for this study.

Primary Research

The autoimmune disease diagnosis market comprises several stakeholders, such as autoimmune disease diagnosis manufacturers and distributors. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. Following is a breakdown of the primary respondents:

Autoimmune Disease Diagnosis Market

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the autoimmune disease diagnosis market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research.
  • The industry's supply chain and market size, in terms of value, have been determined through primary and secondary research processes.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Data Triangulation

After arriving at the overall autoimmune disease diagnosis market size—using the market size estimation processes as explained above—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the autoimmune disease diagnosis industry.

Report Objectives

  • To define, describe, segment, and forecast the autoimmune disease diagnosis market by product, test type, disease, end user, and region
  • To forecast the size of the market with respect to the main regional segments—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To profile key players and comprehensively analyze their market shares and core competencies2 in terms of market developments and growth strategies
  • To track and analyze competitive developments such as collaborations, regulatory approvals, partnerships, acquisitions, and product launches in the autoimmune disease diagnosis market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company's specific needs. The following customization options are available for the autoimmune disease diagnosis market report:

Product Analysis:

  • Product matrix, which gives a detailed comparison of the product portfolios of each company

Company Information:

  • Detailed analysis and profiling of additional market players (Up to 5)
Report Code
MD 5936
Published ON
Apr, 2020
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Autoimmune Disease Diagnosis Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home